Page last updated: 2024-08-21

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Decerebrate Posturing

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with Decerebrate Posturing in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bond, A; Neal, H1

Other Studies

1 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Decerebrate Posturing

ArticleYear
Modification of PGO activity by specific uptake inhibitors fluoxetine, nisoxetine and LR5182.
    Neuropharmacology, 1979, Volume: 18, Issue:10

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cats; Decerebrate State; Dimethylamines; Electroencephalography; Female; Fenclonine; Fluoxetine; Geniculate Bodies; Male; Occipital Lobe; Phenyl Ethers; Pons; Propylamines; Reserpine; Time Factors

1979